U.S. flag

An official website of the United States government

NM_000369.5(TSHR):c.1963_1964del (p.Thr655fs) AND not provided

Germline classification:
Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:
Jun 12, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001570778.5

Allele description [Variation Report for NM_000369.5(TSHR):c.1963_1964del (p.Thr655fs)]

NM_000369.5(TSHR):c.1963_1964del (p.Thr655fs)

Genes:
TSHR-AS1:TSHR antisense RNA 1 [Gene - HGNC]
TSHR:thyroid stimulating hormone receptor [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
14q31.1
Genomic location:
Preferred name:
NM_000369.5(TSHR):c.1963_1964del (p.Thr655fs)
HGVS:
  • NC_000014.9:g.81144021_81144022del
  • NG_009206.1:g.193497_193498del
  • NM_000369.5:c.1963_1964delMANE SELECT
  • NP_000360.2:p.Thr655fs
  • LRG_523t1:c.1963_1964del
  • LRG_523:g.193497_193498del
  • NC_000014.8:g.81610364_81610365del
  • NC_000014.8:g.81610365_81610366del
  • NM_000369.2:c.1963_1964del
  • NM_000369.2:c.1963_1964delAC
Protein change:
T655fs
Links:
OMIM: 603372.0031; dbSNP: rs761918916
NCBI 1000 Genomes Browser:
rs761918916
Molecular consequence:
  • NM_000369.5:c.1963_1964del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Synonyms:
none provided; RECLASSIFIED - ADRA2C POLYMORPHISM; RECLASSIFIED - ADRB1 POLYMORPHISM
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001795126GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Pathogenic
(Jun 12, 2024)
germlineclinical testing

Citation Link,

SCV004297145Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Aug 7, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Germline mutations of TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism.

Alberti L, Proverbio MC, Costagliola S, Romoli R, Boldrighini B, Vigone MC, Weber G, Chiumello G, Beck-Peccoz P, Persani L.

J Clin Endocrinol Metab. 2002 Jun;87(6):2549-55.

PubMed [citation]
PMID:
12050212
See all PubMed Citations (4)

Details of each submission

From GeneDx, SCV001795126.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Identified with a second variant in the TSHR gene in a patient with severe congenital hypothyroidism; please note that this variant is referred to as delAC655 using alternate nomenclature (PMID: 9589691); Identified in the heterozygous state in a patient with nonautoimmune subclinical hypothyroidism; please note that this variant is referred to as T655del using alternate nomenclature (PMID: 12050212); Frameshift variant predicted to result in abnormal protein length as the last 110 amino acids are replaced with 1 different amino acid, and other similar variants have been reported in HGMD; Functional studies demonstrate that this variant, described using alternate nomenclature T655del, leads to a loss of function (PMID: 12050212); This variant is associated with the following publications: (PMID: 14604307, 34200080, 12050212, 34426522, 35177841, 22049173, 9589691)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004297145.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this premature translational stop signal affects TSHR function (PMID: 12050212). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 1204435). This variant is also known as del AC 655; T655X; T655delta-TSHR. This premature translational stop signal has been observed in individual(s) with hypothyroidism (PMID: 9589691, 12050212, 22049173). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs761918916, gnomAD 0.006%). This sequence change creates a premature translational stop signal (p.Thr655Cysfs*2) in the TSHR gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 110 amino acid(s) of the TSHR protein.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jan 25, 2025